Diabetic Ketoacidosis Treatment Market Expected to Reach USD 1.46 Billion by 2036, with Top Players Novo Nordisk, Eli Lilly and Sanofi
The global diabetic ketoacidosis treatment market is projected to increase from USD 940.5 million in 2026 to USD 1.46 billion by 2036, registering a compound annual growth rate (CAGR) of 4.5% during the forecast period, according to Fact.MR. The market was valued at USD 900 million in 2025. Demand is supported by rising disease prevalence, improved diagnosis rates and expanding access to...
0 Reacties 0 aandelen 5 Views 0 voorbeeld
AC Mingle https://acmingle.com